Msi-h Dmmr Colorectal Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-03-15
Clinical Trial Update: A Clinical Trial Evaluating the Efficacy and Safety of IBI310 in Combination With Sintilimab, for Neoadjuvant Treatment of MSI-H/dMMR Resectable Colon Cancer [Phase 3]
A phase 3 clinical trial is evaluating IBI310 in combination with sintilimab as neoadjuvant therapy for resectable MSI-H/dMMR colon cancer; …